FGI-1011A6
FGI-1011A6 is a human monoclonal antibody (mAb) targeting TSG101. FGI-1011A6 can be used in Prostate cancer and Viral infections research[1].
Product Specifications
UNSPSC
12352203
Target
HIV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection
Smiles
[FGI-1011A6]
References & Citations
[1]Sparrow E, et al. Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine. 2016 Oct 26;34 (45) :5442-5448.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1393935-01 0.02 mg (E-Coli)
Recombinant Corynebacterium diphtheriae 3-dehydroquinate synthase (aroB)
Ask
View Details 
MBS1393935-02 0.02 mg (Yeast)
Recombinant Corynebacterium diphtheriae 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1393935-03 0.1 mg (E-Coli)
Recombinant Corynebacterium diphtheriae 3-dehydroquinate synthase (aroB)
Ask
View Details MBS1393935-04 0.1 mg (Yeast)
Recombinant Corynebacterium diphtheriae 3-dehydroquinate synthase (aroB)
Ask
View Details